AMP 2025 Annual Meeting & Expo Recordings

 

 

This collection will give you access to many of the sessions recorded at the 2025 AMP Annual Meeting & Expo and the associated slide decks. CME and CMLE is available for select sessions in this collection. 

 

Unlock On-Demand Access to the Future of Molecular Diagnostics!

Explore cutting-edge content from the AMP Annual Meeting, the premier event for molecular professionals. This on-demand program offers critical updates and expert insights to help you stay ahead in delivering the best patient care.

You can experience a stellar lineup of plenary sessions delivering cutting-edge insights – from automation in sequencing, infectious disease surveillance and discovery, and AI’s ethical dimensions to variant classification, individualized prognosis in multiple myeloma, and RNAseq innovation. A robust selection of workshops and breakout sessions will further explore key topics across genetics, hematopathology, infectious disease, informatics, solid tumors, and a range of technical topics.

View AMP 2025 Program book here.

 

MEMBERSHIP TYPE PRICE
AMP Regular Members $545
AMP Technologist Members $415
AMP Associate Members $285 
Nonmembers $825 
Please note: Those who pre-purchased access to AMP 2025 On-demand Recordings will receive access to these recordings automatically in January 2026.

 

 

  1. Recorded content and associated handouts from AMP 2025 Annual Meeting & Expo - over 40 sessions and 40 hours of content! See below for session titles included in this package.
  2. CME/CMLE credit through December 2028!

 

 

 

 

Continuing education credit is available for many of the scientific sessions of the AMP 2025 Annual Meeting & Expo Recordings. A total of 40.5 CME/CMLE units is available across all of the presentations.

 

 

 


Session Titles: 

(Click on the sections below to review session titles included in this recording)

LDTs Under the Microscope: Regulatory and Legislative Updates

The Advancement of Next Generation Sequencing and Analytics for Pediatric Precision Diagnosis

Best Practices and Future Directions in Paired Tumor-Normal Molecular Profiling for Solid Tumors

Beyond the Genome: Innovative Approaches to Molecular Diagnostics

Case Studies in Genetics

Confronting the Variants of Uncertain Significance (VUS) Conundrum (Plenary)

Implementing Pre-emptive Germline Genomic Testing for Preventive Medicine

Platform Presentations of Selected Genetics Abstracts

Advancing Acute Leukemia Diagnosis: The Role of Methylation Sequencing for Rapid Classification

Case Studies in Hematopathology

Epigenetic Signatures in Lymphoma: Advancing Classification and Insights (partial session)

Genomic Classification and Individualized Prognosis in Multiple Myeloma (Plenary)

Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities

Platform Presentations of Selected Hemepath Abstracts

Uncovering Clinically Significant Gene Fusions & Neoantigens: Challenges and Innovations in Tumor Profiling

Case Studies in Infectious Diseases

Emerging Public Health Threats: Avian Influenza A(H5N1) (partial session)

Optimizing Diagnostic Stewardship: Clinician and Lab Director Perspectives on Effective Test Utilization

Platform Presentations of Selected Infectious Diseases Abstracts

Self-Collection: Navigating the Variables and Balancing the Pros and Cons

Small Game Hunting (Plenary)

Applications of AI and Machine Learning for Clinical Implications

Applications of Foundation Models in Molecular

Computational Assessment of Tumor Content (partial session)

Developing Robust Bioinformatic Pipelines and Regulatory Requirements

Ethical Frontiers: The Promise and Perils of Healthcare AI in a Socially Connected World (Plenary)

Integrated Genomics Viewer Workshop

Platform Presentations of Selected Informatics Abstracts

Uncovering Clinically Significant Gene Fusions & Neoantigens: Challenges and Innovations in Tumor Profiling

Advances in Oncogenic Evaluation and Nomenclature of Gene Fusions in Solid Tumors

Case Studies in Solid Tumors I

Case Studies in Solid Tumors II

From Targeted NGS Panels to Virtual Panels in the Era of Exome Sequencing

Leveraging RNA Sequencing for Splice Variant Discovery and Somatic Variant Prioritization in Precision Oncology (Plenary)

Platform Presentations of Selected Solid Tumor Abstracts

Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer: A Joint Consensus Recommendation of the Association of Molecular Pathology, Association of Cancer Care Centers, and College of American Pathologists

Transforming Cancer Care with Cell-Free DNA Testing

Uncovering Clinically Significant Gene Fusions & Neoantigens: Challenges and Innovations in Tumor Profiling

A Refresher in R: Using R in Validations in the Clinical Pathology Lab

Automate to Innovate: Practical Insights for Molecular Diagnostics Through Engineering Efficiency and Smart Automation

Automation for Tumour Sequencing at Scale (Plenary)

Platform Presentations of Selected Technical Topic Abstracts

Technologist Session

Women in Molecular Pathology: Career Perspectives from Technologists and Pathologists (partial session)


 How to Access: 

  • To purchase all the session recordings, click the "Enroll" button at the top of the page.
  • If you have pre-purchased, you do not need to Enroll. The course will be available in your classroom at https://educate.amp.org/my 


CE Information: 

CME and CMLE is available for most of the recorded content. Eight sessions are ineligible for CE: Beyond the Genome: Innovative Approaches to Molecular Diagnostics, Platform Presentations of Selected Informatics Abstracts, Platform Presentations of Selected Solid Tumor Abstracts, Platform Presentations of Selected Technical Topic Abstracts,  Self-Collection: Navigating the Variables and Balancing the Pros and Cons, Automate to Innovate: Practical Insights for Molecular Diagnostics Through Engineering Efficiency and Smart Automation, Uncovering Clinically Significant Gene Fusions & Neoantigens: Challenges and Innovations in Tumor Profiling, and Technologist Session

CME/CMLE credit available: Maximum of 40.5 hrs
Continuing Education Credit must be claimed by December 31, 2028

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of ASCP and the Association for Molecular Pathology. ASCP is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement – The ASCP designates this live activity for a maximum of 40.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Medical Laboratory Education (CMLE)

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for up to 40.5 CMLE credits.  ASCP CMLE credits are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program.


If you have questions, please email AMPEducation@amp.org.